These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35400238)

  • 1. Ubiquitin C-terminal hydrolase L1 promotes lymph node metastasis in small cell neuroendocrine carcinomas of the cervix.
    Zhang Y; Ding J; Zhang X; Hua K
    J Int Med Res; 2022 Apr; 50(4):3000605221087620. PubMed ID: 35400238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin C-terminal hydrolase-L1 has prognostic relevance and is a therapeutic target for high-grade neuroendocrine lung cancers.
    Shimada Y; Kudo Y; Maehara S; Matsubayashi J; Otaki Y; Kajiwara N; Ohira T; Minna JD; Ikeda N
    Cancer Sci; 2020 Feb; 111(2):610-620. PubMed ID: 31845438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of iTRAQ-based quantitative proteomic identification of CHGA and UCHL1 correlated with lymph node metastasis in colorectal carcinoma.
    Lee KC; Chen HH; Cheng KC; Liu TT; Lee KF; Teng CC; Huang CY; Hsieh MC; Kuo HC
    J Cell Mol Med; 2023 Jul; 27(14):2004-2020. PubMed ID: 37246623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
    Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
    Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas.
    Liu S; Chai T; Garcia-Marques F; Yin Q; Hsu EC; Shen M; Shaw Toland AM; Bermudez A; Hartono AB; Massey CF; Lee CS; Zheng L; Baron M; Denning CJ; Aslan M; Nguyen HM; Nolley R; Zoubeidi A; Das M; Kunder CA; Howitt BE; Soh HT; Weissman IL; Liss MA; Chin AI; Brooks JD; Corey E; Pitteri SJ; Huang J; Stoyanova T
    Cell Rep Med; 2024 Feb; 5(2):101381. PubMed ID: 38244540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-cell neuroendocrine carcinoma of the cervix accompanied by adenocarcinoma and high-grade squamous intraepithelial lesion.
    Okabe A; Ishida M; Noda Y; Okano K; Sandoh K; Fukuda H; Kita M; Okada H; Tsuta K
    Diagn Cytopathol; 2022 Oct; 50(10):E285-E288. PubMed ID: 35652304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma.
    Yao J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Wang X; Dai J; Xu X
    World J Surg Oncol; 2022 May; 20(1):153. PubMed ID: 35546675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
    Miyoshi AI; Ueda Y; Kurita T; Kimura T; Yoshino K
    Anticancer Res; 2023 Apr; 43(4):1397-1405. PubMed ID: 36974776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
    Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT
    Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dedifferentiation of neuroendocrine carcinoma of the uterine cervix in hypoxia.
    Kubota S; Tanaka M; Endo H; Ito Y; Onuma K; Ueda Y; Kamiura S; Yoshino K; Kimura T; Kondo J; Inoue M
    Biochem Biophys Res Commun; 2020 Apr; 524(2):398-404. PubMed ID: 32007268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma in situ admixed with small cell neuroendocrine carcinoma of the cervix: A case report with cytological features.
    Nishiumi Y; Nishimura T; Kashu I; Aoki T; Itoh R; Tsuta K; Ishida M
    Diagn Cytopathol; 2018 Sep; 46(9):752-755. PubMed ID: 29656585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
    Masuda M; Iida K; Iwabuchi S; Tanaka M; Kubota S; Uematsu H; Onuma K; Kukita Y; Kato K; Kamiura S; Nakajima A; Coppo R; Kanda M; Yoshino K; Ueda Y; Morii E; Kimura T; Kondo J; Okada-Hatakeyama M; Hashimoto S; Inoue M
    Am J Pathol; 2024 Mar; 194(3):415-429. PubMed ID: 38103888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting squamous cell carcinoma and high-grade neuroendocrine carcinoma, small cell type: a rare collision in cervix.
    Kaushal S; Mathur SR; Kumar S
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29778998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
    Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
    J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
    Jia Q; Wang H; Xiao X; Sun Y; Tan X; Chai J; Yang Y; Yin Z; Li M; Wang K; Liu J
    Pathol Res Pract; 2023 Jul; 247():154574. PubMed ID: 37257242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways.
    Gu YY; Yang M; Zhao M; Luo Q; Yang L; Peng H; Wang J; Huang SK; Zheng ZX; Yuan XH; Liu P; Huang CZ
    Tumour Biol; 2015 Nov; 36(11):8379-87. PubMed ID: 26018507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.
    Takami Y; Nakagami H; Morishita R; Katsuya T; Cui TX; Ichikawa T; Saito Y; Hayashi H; Kikuchi Y; Nishikawa T; Baba Y; Yasuda O; Rakugi H; Ogihara T; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2184-90. PubMed ID: 17690318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
    Mabuchi S; Komura N; Sasano T; Sakata M; Matsuzaki S; Hisa T; Kamiura S; Morishima T; Miyashiro I
    Curr Oncol; 2023 Oct; 30(11):9428-9436. PubMed ID: 37999102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Ubiquitin C-terminal Hydrolase L1 Is Associated With Poor Prognosis in Endometrial Cancer Patients.
    Nakao K; Hirakawa T; Suwa H; Kogure K; Ikeda S; Yamashita S; Minegishi T; Kishi H
    Int J Gynecol Cancer; 2018 May; 28(4):675-683. PubMed ID: 29489474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.